E146-1104 Screening compound: N-(6-methoxy-1,3-benzothiazol-2-yl)-1-methyl-1H,4H-chromeno[4,3-c]pyrazole-3-carboxamide

E146-1104 Screening compound: N-(6-methoxy-1,3-benzothiazol-2-yl)-1-methyl-1H,4H-chromeno[4,3-c]pyrazole-3-carboxamide
E146-1104 Screening compound: N-(6-methoxy-1,3-benzothiazol-2-yl)-1-methyl-1H,4H-chromeno[4,3-c]pyrazole-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E146-1104
N-(6-methoxy-1,3-benzothiazol-2-yl)-1-methyl-1H,4H-chromeno[4,3-c]pyrazole-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E146-1104

Molecular Formula

C20H16N4O3S (C20 H16 N4 O3 S)

Compound Name

N-(6-methoxy-1,3-benzothiazol-2-yl)-1-methyl-1H,4H-chromeno[4,3-c]pyrazole-3-carboxamide

IUPAC name

N-(6-methoxy-13-benzothiazol-2-yl)-1-methyl-1H4H-chromeno[43-c]pyrazole-3-carboxamide

SMILES

Cn1nc(C(Nc2nc(ccc(OC)c3)c3s2)=O)c2c1-c(cccc1)c1OC2

InChI

InChI=1S/C20H16N4O3S/c1-24-18-12-5-3-4-6-15(12)27-10-13(18)17(23-24)19(25)22-20-21-14-8-7-11(26-2)9-16(14)28-20/h3-9H,10H2,1-2H3,(H,21,22,25)

InChI Key

QNZQMEZYPNTXSY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14842889

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

392.44

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.816

Distribution Coefficient, logD

3.816

Water Solubility, LogSw

-4.13

Polar Surface Area

63.407

Acid Dissociation Constant (pKa)

10.70

Base Dissociation Constant (pKb)

1.23

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

15.00

E146-1104 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-Inflammatory Library (24602 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein-Protein Interaction Library (218420 compounds)

Targeted Diversity Library (40567 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Immune system
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Kinases
Mechanism of action:
  • PPI modulators
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E146-1104 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E146-1104?
Check Price and Availability of E146-1104, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E146-1104 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E146-1104
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E146-1104
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E146-1104 available by request